Ftse Mib
34.243,14
-0,39%
DAX
18.518,67
-0,44%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.811,10
-3,15%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
25/01/201814:05InvestorsHub NewsWireTraders News Source Issues Stocks on Watch and a New Feature ReportAMEX:BPMXBioPharmX Corporation
16/01/201822:13Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
16/01/201818:45Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:BPMXBioPharmX Corporation
12/01/201815:15PR Newswire (US)BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This MonthAMEX:BPMXBioPharmX Corporation
10/01/201800:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
12/12/201722:19Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
07/12/201722:15PR Newswire (US)BioPharmX Reports Third Quarter 2018 Financial ResultsAMEX:BPMXBioPharmX Corporation
04/12/201715:15PR Newswire (US)BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-inflammatory Properties for the Tr...AMEX:BPMXBioPharmX Corporation
30/11/201723:33Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
22/11/201712:09Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)AMEX:BPMXBioPharmX Corporation
21/11/201715:05PR Newswire (US)BioPharmX Corporation Announces Pricing of Public OfferingAMEX:BPMXBioPharmX Corporation
21/11/201712:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
20/11/201723:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)AMEX:BPMXBioPharmX Corporation
08/11/201715:15PR Newswire (US)BioPharmX Receives Concurrence from FDA on Phase 3 Acne Study PlansAMEX:BPMXBioPharmX Corporation
23/10/201722:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
19/10/201723:29Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BPMXBioPharmX Corporation
18/10/201716:30PR Newswire (US)BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017AMEX:BPMXBioPharmX Corporation
11/10/201716:30PR Newswire (US)BioPharmX Collaborates with Wellman Center for Photomedicine to Develop Pioneering, Cost-Effective Technique to Visualize Dru...AMEX:BPMXBioPharmX Corporation
13/09/201715:00PR Newswire (US)BioPharmX Reports Second Quarter 2018 Financial ResultsAMEX:BPMXBioPharmX Corporation
12/09/201713:30PR Newswire (US)BioPharmX Announces Preliminary Data from Rosacea Feasibility StudyAMEX:BPMXBioPharmX Corporation
05/09/201715:15PR Newswire (US)BioPharmX to Present at Rodman & Renshaw 19th Annual Global Investment ConferenceAMEX:BPMXBioPharmX Corporation
17/08/201722:03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BPMXBioPharmX Corporation
08/08/201720:43Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
27/07/201715:15PR Newswire (US)Summer AAD Panel to Discuss BPX-01 for Acne and RosaceaAMEX:BPMXBioPharmX Corporation
24/07/201712:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:BPMXBioPharmX Corporation
13/07/201715:15PR Newswire (US)BioPharmX To Present Phase 2b Clinical Trial Data at National DEF Essential Resource Meeting 2017AMEX:BPMXBioPharmX Corporation
22/06/201715:15PR Newswire (US)BioPharmX to Present Phase 2b Clinical Trial Acne Data at Alabama Dermatology Society Summer SymposiumAMEX:BPMXBioPharmX Corporation
14/06/201715:00PR Newswire (US)BioPharmX Invited to Present at World Preclinical CongressAMEX:BPMXBioPharmX Corporation
13/06/201722:05PR Newswire (US)BioPharmX Reports First Quarter 2018 Financial ResultsAMEX:BPMXBioPharmX Corporation
07/06/201712:15PR Newswire (US)BioPharmX to Report First Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

NASDAQ
CSLRW
Complete Solaria
NASDAQ
PMGMW
Priveterra Acquisition C...
NASDAQ
XWEL
XWELL
NASDAQ
CALA
Calithera Biosciences
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network